Author Information
Genetic testing now accounts for 43 percent of all Medicare Part B laboratory spending
Cuts to reimbursement rates under PAMA have been pushed back again by Congress, this time to January 2027
However, attorney Danielle Sloane urges labs to be proactive about potential PAMA reporting requirements on Jan. 31 if the bill doesn’t pass quickly
Better clinical laboratory test data reporting would allow ‘Medicare rates to be more appropriately set,’ says Susan Van Meter
Federal prosecutors continue to target situations where third-party recruiters influence test ordering
CMS tweaked its CE, documentation, and on-site visit requirements for directors
AMP Annual Meeting attendees showed strong interest in the blood test
Bill that ended government shutdown includes provision to hold off PAMA cuts
However, a proposed bill called the RESULTS Act is racing to thwart the cuts to lab test reimbursement rates
Two revenue cycle management experts explain opportunities that clinical laboratories have with artificial intelligence
